Pricing Log in Create free account

Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) vs eFFECTOR Therapeutics, Inc. (EFTR)

Biodexa Pharmaceuticals PLC Unsponsored ADR and eFFECTOR Therapeutics, Inc. are both Biotechnology companies. Biodexa Pharmaceuticals PLC Unsponsored ADR is the larger, with a market value of $440.0K against $200.0K — 2.2× the size. Biodexa Pharmaceuticals PLC Unsponsored ADR grew revenue faster over the last twelve months: 60.2% against −86.2%. eFFECTOR Therapeutics, Inc. has the higher net margin (0.00% vs −1,155.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Biodexa Pharmaceuticals PLC Unsponsored ADR leads on 6 and eFFECTOR Therapeutics, Inc. on 4.

Valuation

Metric BDRX EFTR Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.20 n/m 0.64
EV/Sales (2.81) 3.20 9.21
Earnings yield (555.04%) 0.00% (33.15%)
Free cash flow yield 0.00% 0.00% (25.50%)

Profitability

Metric BDRX EFTR Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin (1,155.70%) 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 1,737.63% (56.36%)
Return on assets 0.00% (141.18%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BDRX EFTR Biotechnology median
Revenue growth (TTM) 60.22% (86.21%) 6.02%
EPS growth (last fiscal year) 89.68% (19.05%) 30.26%
Revenue growth, 5-year CAGR (28.78%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDRX EFTR Biotechnology median
Debt to equity 0.00 22.87 0.00
Current ratio 2.41 1.03 4.72
Net debt to EBITDA 1.00 (0.03) 0.96

Dividend

Metric BDRX EFTR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BDRX EFTR Biotechnology median
Market cap 440.00k 200.00k 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack